Focus on Haemostasis

Stago continues to ditch paper!

Stago continues to ditch paper!

In April 2017, Stago officially launched its IFU (Instruction for Use) platform at www.stago.com so that customers worldwide could visit and download reagent instructions, analyser reference manuals and safety data sheets that they need for their day-to-day work.

Read more
STA-Liatest D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion

STA-Liatest D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion

On December 10th, 2016 the US Food and Drug Administration (FDA) cleared STA-Liatest D-Di for the exclusion of the diagnosis of Deep Vein Thrombosis (DVT) on data reported from the multi-national, DiET study. Exclusion of the diagnosis of Pulmonary embolism (PE) was previously 510(k) cleared in 2014.

Read more
 New publication confirms efficacy and excellent performances of STA-Liatest D-Di for excluding Pulmonary Embolism

New publication confirms efficacy and excellent performances of STA-Liatest D-Di for excluding Pulmonary Embolism

Results of the DiET Study have been recently published in Blood coagulation fibrinolysis, July 2016.

Read more
Diagnostica Stago S.A.S enters into Joint Research Agreement With Bristol-Myers Squibb

Diagnostica Stago S.A.S enters into Joint Research Agreement With Bristol-Myers Squibb

Partnership to develop assay for measuring concentration of the oral Factor Xa inhibitor ELIQUIS® (apixaban).

Read more
New ISTH Guidelines for Lupus Anticoagulant Detection

New ISTH Guidelines for Lupus Anticoagulant Detection

In 2009, ISTH has revised its criteria for AntiPhospholipid Syndrome (APS) detection previously defined in 1995. What's new?

Read more